Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kunzah Jamal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Biochemical Journal|October 28, 2016
Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487Helen R Heathcote, Sarah J Mancini, Anastasiya Strembitska, et al.
Cancer Research Communications|March 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP InhibitionKunzah Jamal, Alessandro Galbiati, Joshua Armenia, et al.
Molecular Cell|May 17, 2017
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell DeathIsabel Jaco, Alessandro Annibaldi, Najoua Lalaoui, et al.
EMBO Molecular Medicine|May 19, 2020
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaHenry G Smith, Kunzah Jamal, Jasbani Hs Dayal, et al.
Cell Death and Differentiation|December 4, 2020
Primidone blocks RIPK1-driven cell death and inflammationTheresa Riebeling, Kunzah Jamal, Rebecca Wilson, et al.
Cell Reports|April 12, 2018
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic PotentialRebecca Feltham, Kunzah Jamal, Tencho Tenev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and TrapperGiuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1Anna D Staniszewska, Domenic Pilger, Sonja J Gill, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Biochemical Journal|October 28, 2016
Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487Helen R Heathcote, Sarah J Mancini, Anastasiya Strembitska, et al.
Cancer Research Communications|March 27, 2023
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP InhibitionKunzah Jamal, Alessandro Galbiati, Joshua Armenia, et al.
Molecular Cell|May 17, 2017
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell DeathIsabel Jaco, Alessandro Annibaldi, Najoua Lalaoui, et al.
EMBO Molecular Medicine|May 19, 2020
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaHenry G Smith, Kunzah Jamal, Jasbani Hs Dayal, et al.
Cell Death and Differentiation|December 4, 2020
Primidone blocks RIPK1-driven cell death and inflammationTheresa Riebeling, Kunzah Jamal, Rebecca Wilson, et al.
Cell Reports|April 12, 2018
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic PotentialRebecca Feltham, Kunzah Jamal, Tencho Tenev, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2022
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and TrapperGiuditta Illuzzi, Anna D Staniszewska, Sonja J Gill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1Anna D Staniszewska, Domenic Pilger, Sonja J Gill, et al.
Journal of Medicinal Chemistry|November 3, 2025
Use of Direct-to-Biology Strategies for the Discovery of 2'-Deoxynucleoside 5'-Monophosphate N-Glycosidase (DNPH1) PROTACsNiall A Anderson, Bernard Barlaam, Argyrides Argyrou, et al.
Pageof 1